美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
70436-161-02	70436-161	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate	Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20210412	N/A	ANDA	ANDA213858	Slate Run Pharmaceuticals, LLC	TOLTERODINE TARTRATE	4 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-161-02)
70436-161-04	70436-161	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate	Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20210412	N/A	ANDA	ANDA213858	Slate Run Pharmaceuticals, LLC	TOLTERODINE TARTRATE	4 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-161-04)
70436-161-06	70436-161	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate	Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20210412	N/A	ANDA	ANDA213858	Slate Run Pharmaceuticals, LLC	TOLTERODINE TARTRATE	4 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-161-06)
70436-160-06	70436-160	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate	Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20210412	N/A	ANDA	ANDA213858	Slate Run Pharmaceuticals, LLC	TOLTERODINE TARTRATE	2 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-160-06)
70436-160-04	70436-160	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate	Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20210412	N/A	ANDA	ANDA213858	Slate Run Pharmaceuticals, LLC	TOLTERODINE TARTRATE	2 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-160-04)
70436-160-02	70436-160	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate	Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20210412	N/A	ANDA	ANDA213858	Slate Run Pharmaceuticals, LLC	TOLTERODINE TARTRATE	2 mg/1	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-160-02)